These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21420876)

  • 1. Cancer origin in committed versus stem cells: hypothetical antineoplastic mechanism/s associated with stem cells.
    Torres-Montaner A
    Crit Rev Oncol Hematol; 2011 Nov; 80(2):209-24. PubMed ID: 21420876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hypothetical anti-neoplastic mechanism associated to reserve cells.
    Torres-Montaner A; Hughes D
    J Theor Biol; 2004 Nov; 231(2):239-48. PubMed ID: 15380388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cells and cancer: an intimate relationship.
    Burkert J; Wright NA; Alison MR
    J Pathol; 2006 Jul; 209(3):287-97. PubMed ID: 16770755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase and cancer stem cells.
    Armanios M; Greider CW
    Cold Spring Harb Symp Quant Biol; 2005; 70():205-8. PubMed ID: 16869755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells.
    Yamaoka E; Hiyama E; Sotomaru Y; Onitake Y; Fukuba I; Sudo T; Sueda T; Hiyama K
    Int J Oncol; 2011 Jul; 39(1):5-11. PubMed ID: 21573488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell biology and the cellular pathways of carcinogenesis.
    Gudjonsson T; Magnusson MK
    APMIS; 2005; 113(11-12):922-9. PubMed ID: 16480458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stem cell--is there any role in tumorigenic activity].
    Saigal S; Bhargava A
    Turk Patoloji Derg; 2011 May; 27(2):93-7. PubMed ID: 21630193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomeres and telomerase in cancer stem cells.
    Ju Z; Rudolph KL
    Eur J Cancer; 2006 Jun; 42(9):1197-203. PubMed ID: 16644207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To what extent are the "sets" of biologic properties expressed by hypoxic cancer cells and by cancer "stem" cells equivalent, intersecting, disjoint or complementary? Some implications for the design of cancer therapies.
    Anderson KM; Tsui P; Guinan P; Rubenstein M
    Med Hypotheses; 2007; 68(1):166-8. PubMed ID: 16934948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase regulation and progressive telomere shortening of rat hepatic stem-like epithelial cells during in vitro aging.
    Oh BK; Lee CH; Park C; Park YN
    Exp Cell Res; 2004 Aug; 298(2):445-54. PubMed ID: 15265692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells.
    Burns JS; Abdallah BM; Guldberg P; Rygaard J; Schrøder HD; Kassem M
    Cancer Res; 2005 Apr; 65(8):3126-35. PubMed ID: 15833842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer initiating cell theory: popularity and controversies].
    Chen H; Huang Q; Dong J; Lan Q
    Ai Zheng; 2006 Jun; 25(6):779-84. PubMed ID: 16764781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neosis--a paradigm of self-renewal in cancer.
    Rajaraman R; Rajaraman MM; Rajaraman SR; Guernsey DL
    Cell Biol Int; 2005 Dec; 29(12):1084-97. PubMed ID: 16316756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue repair and stem cell renewal in carcinogenesis.
    Beachy PA; Karhadkar SS; Berman DM
    Nature; 2004 Nov; 432(7015):324-31. PubMed ID: 15549094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good cells gone bad: the cellular origins of cancer.
    Wang JC
    Trends Mol Med; 2010 Mar; 16(3):145-51. PubMed ID: 20149745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers.
    Sell S; Pierce GB
    Lab Invest; 1994 Jan; 70(1):6-22. PubMed ID: 8302019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition.
    Castelo-Branco P; Zhang C; Lipman T; Fujitani M; Hansford L; Clarke I; Harley CB; Tressler R; Malkin D; Walker E; Kaplan DR; Dirks P; Tabori U
    Clin Cancer Res; 2011 Jan; 17(1):111-21. PubMed ID: 21208905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining the telomere-telomerase hypothesis of aging and cancer.
    Holt SE; Shay JW; Wright WE
    Nat Biotechnol; 1996 Jul; 14(7):836-9. PubMed ID: 9631006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells: redefining the paradigm of cancer treatment strategies.
    Dean M
    Mol Interv; 2006 Jun; 6(3):140-8. PubMed ID: 16809475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.